| |
| |
|
| Insider
Information: |
Brum Lynne H |
| Relationship: |
VP, Planning and Corpo... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
154,525 |
|
|
Indirect Shares
|
856,224 |
|
|
| Direct
Value |
$21,061,081 |
|
|
|
Indirect Value
|
$3,104,937 |
|
|
| Total
Shares |
1,010,749 |
|
|
| Total
Value |
$24,166,018 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
VP, Strategic Communic... |
2006-05-08 |
46,199 |
2006-05-08 |
6,803 |
Premium* |
|
|
Altus Pharmaceuticals Inc. |
ALTUQ |
Director |
|
0 |
2006-01-31 |
817,749 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
VP, Planning and Corpo... |
2024-02-15 |
108,326 |
2024-02-15 |
31,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2005-12-06 |
4 |
OE |
$9.50 |
$19,000 |
D/D |
2,000 |
46,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-17 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
45,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-23 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
45,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-31 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
45,196 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-06 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-02-13 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-02-21 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-02-27 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-06 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-13 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-20 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
49,587 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-03-27 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
47,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-04-03 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
47,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-04-10 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
47,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-04-17 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
47,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-04-24 |
4 |
OE |
$15.56 |
$15,560 |
D/D |
1,000 |
47,199 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-05-01 |
4 |
OE |
$13.67 |
$32,648 |
D/D |
2,250 |
47,449 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
VP, Strategic Communications |
• – – |
2006-05-08 |
4 |
OE |
$13.67 |
$32,648 |
D/D |
2,250 |
47,449 |
|
- |
|
| ALTUQ |
Altus Pharmaceuticals Inc... |
officerTitle |
– • – |
2006-01-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
436,153 |
|
- |
|
| ALTUQ |
Altus Pharmaceuticals Inc... |
officerTitle |
– • – |
2006-01-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
450,000 |
|
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Marketing and Corp Comm |
• – – |
2016-04-01 |
4 |
D |
$1.86 |
$18,793 |
D/D |
(10,104) |
96,866 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning & Comms |
• – – |
2017-04-01 |
4 |
D |
$0.37 |
$2,735 |
D/D |
(7,392) |
89,474 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning & Comms |
• – – |
2019-04-01 |
4 |
D |
$1.16 |
$788 |
D/D |
(679) |
7,469 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning & Comms |
• – – |
2020-08-11 |
4 |
D |
$6.55 |
$3,845 |
D/D |
(587) |
3,599 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
VP Planning & Comms |
• – – |
2021-02-11 |
4 |
D |
$22.77 |
$15,780 |
D/D |
(693) |
2,906 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
